Michael Henry Fiore Sells 3,142 Shares of HealthEquity (NASDAQ:HQY) Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the sale, the executive vice president directly owned 59,113 shares in the company, valued at approximately $5,615,735. This represents a 5.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

HealthEquity Stock Down 2.5%

Shares of NASDAQ:HQY traded down $2.30 during midday trading on Tuesday, reaching $88.34. The company had a trading volume of 1,068,359 shares, compared to its average volume of 1,017,978. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The business’s 50 day moving average price is $83.63 and its 200 day moving average price is $86.61. The stock has a market cap of $7.41 billion, a PE ratio of 33.09, a P/E/G ratio of 1.60 and a beta of 0.19. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $116.65.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The firm had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts forecast that HealthEquity, Inc. will post 3.84 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have weighed in on HQY shares. Barrington Research reissued an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, March 19th. KeyCorp reissued an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Barclays lowered their price target on HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 18th. Finally, Raymond James Financial set a $100.00 price target on HealthEquity in a research report on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $111.53.

Hedge Funds Weigh In On HealthEquity

A number of large investors have recently made changes to their positions in HQY. Vanguard Group Inc. boosted its stake in shares of HealthEquity by 2.9% in the third quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock valued at $828,883,000 after buying an additional 243,549 shares during the period. Wasatch Advisors LP boosted its stake in shares of HealthEquity by 9.3% in the first quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock valued at $601,949,000 after buying an additional 613,288 shares during the period. Geode Capital Management LLC boosted its stake in shares of HealthEquity by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock valued at $201,685,000 after buying an additional 5,671 shares during the period. Westfield Capital Management Co. LP boosted its stake in shares of HealthEquity by 13.7% in the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock valued at $178,864,000 after buying an additional 235,794 shares during the period. Finally, William Blair Investment Management LLC bought a new stake in shares of HealthEquity in the fourth quarter valued at approximately $169,956,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.